News

All news
  • 47 regions are on the track. Are “pilots” ready ?!

    Health issues come to the fore in the context of the goals and objectives of the development of our country. According to the order of the President of the Russian Federation Vladimir Putin, by July 1, 2020, the government needs to submit methodological proposals for a pilot project. Today, at the federal level, there is no understanding of how drug reimbursement models will be implemented. There are several suggestions, but there is no final decision as to which drug reimbursement system will be implemented, and there are no legal acts.

  • ARPM: 10 directions of pharmaceutical industry development

    February is the time to set goals for the coming year. The Director General of the Association of Russian Pharmaceutical Manufacturers Victor Dmitriev summed up the results of 2019, announced plans and dreams for 2020 at the meeting of the Russian Association of Pharmaceutical Marketing (RAPM). Welcoming the audience, the head of the ARPM noted that "it is impossible to change the past, but to draw conclusions, to analyze errors is simply necessary."

  • ARPM: are people behind the numbers or what is hidden behind the targets?

    In 2020, the national regime regarding the procurement of goods, work, services does not apply to products from the EAEU countries (Belarus, Kazakhstan, Armenia, Kyrgyzstan). Products from these states are not equivalent to foreign products under the national regime. These measures are designed to simplify and maintain the share of EAEU goods at the level of 50%. The government prepared the relevant amendments in 44-FL “On the contract system”. National regime includes preferences, restrictions and prohibitions. So, according to the new rules, it is forbidden to purchase foreign products for the defense and security of the country, but otherwise the “Third Extra” mechanism and price preferences will be applied.

  • "Regulatory guillotine" of alcohol-containing medicines was launched

    On January 17, a meeting of a working group from the expert and business community on the implementation of the “regulatory guillotine” in the production and turnover of alcoholic beverages took place. Ilya Lomakin-Rumyantsev, Director of the Center for Consumer Market Development at the Moscow School of Management Skolkovo, was elected Chairman of the working group. Olga Pentegova, Deputy Director General of the Association of Russian Pharmaceutical Manufacturers, represents the pharmaceutical industry.

  • ARPM Strategic Plans and Hot Topics for Today

    The transition period for the implementation of drug labeling will be extended by six months. “Medicinal products for medical use manufactured before July 1, 2020 are subject to storage, transportation, dispensing, sale, transfer, use without identification means until the expiration date,” the document says. The amendment adopted in the second reading allows participants in the process to register, test the system and debug business processes. In November, according to Elena Kudryavtseva, deputy head of the Office for Organization of State Quality Control of Medical Products of Federal Service for Surveillance in Healthcare (Roszdravnadzor), the industry’s readiness was 30%...

  • Denis Chetverikov, President of Akrikhin, was elected Chairman of the ARPM Supervisory Board

    On December 4, the annual General Meeting of the Association of Russian Pharmaceutical Manufacturers was held. The event was attended by the leaders of the ARPM member companies, representatives of state authorities, and pharmaceutical market experts.
    Denis Chetverikov, President of Akrikhin, was unanimously elected Chairman of the ARPM Supervisory Board. In his welcoming speech, he thanked his colleagues for their trust and noted that the member companies of the Association are key investors ...

  • Industry readiness for labeling as average hospital temperature

    The Association of Russian Pharmaceutical Manufacturers held a round table “General preparedness for drug labeling” as part of the business program of the Pharmtech & Ingredients 2019 exhibition. The panelists once again discussed the degree of readiness of the industry to launch a drug movement monitoring system (DMM), gave an analysis of the first steps of labeling according to the program, 7 high-cost nosologies and identified problems that need to be addressed.

Projects

All projects

Membership of ARFP in the Organizations

Russian Union of Industrialists
and Entrepreneurs (RSPP)

rspp.ru

Chamber of Commerce and Industry (CCI)
of the Russian Federation

tpprf.ru

Awards of Association

Partners of association